Optimizing risk stratification for intermediate-risk prostate cancer – the prognostic value of baseline health-related quality of life.

MLA

Westhofen, Thilo, et al. “Optimizing Risk Stratification for Intermediate-Risk Prostate Cancer – the Prognostic Value of Baseline Health-Related Quality of Life.” World Journal of Urology, vol. 42, no. 1, Oct. 2024, pp. 1–7. EBSCOhost, https://doi.org/10.1007/s00345-024-05298-2.

APA

Westhofen, T., Buchner, A., Lennartz, S., Rodler, S., Eismann, L., Aydogdu, C., Askari-Motlagh, D., Berg, E., Feyerabend, E., Kazmierczak, P., Jokisch, F., Becker, A., Stief, C. G., & Kretschmer, A. (2024). Optimizing risk stratification for intermediate-risk prostate cancer – the prognostic value of baseline health-related quality of life. World Journal of Urology, 42(1), 1–7. https://doi.org/10.1007/s00345-024-05298-2

Chicago

Westhofen, Thilo, Alexander Buchner, Simon Lennartz, Severin Rodler, Lennert Eismann, Can Aydogdu, Darjusch Askari-Motlagh, et al. 2024. “Optimizing Risk Stratification for Intermediate-Risk Prostate Cancer – the Prognostic Value of Baseline Health-Related Quality of Life.” World Journal of Urology 42 (1): 1–7. doi:10.1007/s00345-024-05298-2.